(IONS) |
| 0 (0%) 04-14 05:04 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 90.13 |
| Resistance 1: | 77.17 |
| Pivot price: | 73.79 |
| Support 1: | 72.06 |
| Support 2: | 68.90 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -2.380 |
| Book Value | 2.990 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.074 |
| Profit Margin (%) | -40.41 |
| Operating Margin (%) | -105.47 |
| Return on Assets (ttm) | -7.3 |
| Return on Equity (ttm) | -70.8 |
Company news
Tue, 14 Apr 2026
What Ionis Pharmaceuticals (IONS)'s Renewed Analyst Focus on Tryngolza Means For Shareholders - simplywall.st
Mon, 13 Apr 2026
Lithium-ion battery fire at Rahway warehouse under investigation - Central New Jersey News
Mon, 13 Apr 2026
Powering the Future: Beyond Lithium-Ion - Tech Briefs
Mon, 13 Apr 2026
Combining ion pumps and click chemistry enables precise drug release in the body - Phys.org
Mon, 13 Apr 2026
Freestanding silicon anode design improves fast charging and cycle life in lithium-ion batteries - Tech Xplore
Mon, 13 Apr 2026
Efficient extraction of tetravalent actinide from nitric acid feeds using tri- N -octyl methyl ammonium N -dodecyl sulphate functionalized task-specific ionic liquid - Nature
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
